Yuyu Pharma Announces First Patient Enrolled in Phase 2 Clinical Study Evaluating YP-P10 Ophthalmic Solution for the Treatment of Dry Eye Disease
SEOUL, South Korea, July 20, 2022 /PRNewswire/ — Yuyu Pharma announces the enrollment of the first patient in…